Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought
Publication year
2018Source
World Journal of Urology, 36, 10, (2018), pp. 1621-1627ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Urology
Health Evidence
Journal title
World Journal of Urology
Volume
vol. 36
Issue
iss. 10
Page start
p. 1621
Page end
p. 1627
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 15: Urological cancers RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [188575]
- Faculty of Medical Sciences [74223]
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.